David John Sugarbaker

Q: What Schools Are Affiliated With David John Sugarbaker

David John Sugarbaker is affiliated with the following schools: Wayne State University, University of Chicago, Baylor College of Medicine, Massachusetts General Hospital, Virginia Tech, Harvard University

David John Sugarbaker's AcademicInfluence.com Rankings

Philosophy

#6580

World Rank

#9637

Historical Rank

Logic

#3726

World Rank

#4925

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is David John Sugarbaker Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David John Sugarbaker's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. (1999) (3211)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses (2001) (1518)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. (2001) (1413)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. (2008) (1229)
Non-small cell lung cancer clinical practice guidelines in oncology. (2006) (1010)
Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context (2009) (1003)
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. (2004) (958)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. (1999) (926)
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer (2008) (923)
Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. (2002) (898)
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. (2008) (838)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations (2016) (621)
Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. (1993) (581)
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. (2005) (545)
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. (2012) (535)
A clinical prediction rule for delirium after elective noncardiac surgery. (1994) (535)
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. (2005) (532)
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. (2007) (516)
Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia (2004) (472)
Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. (2004) (392)
A Clinical Prediction Rule for Delirium After Elective Noncardiac Surgery (1994) (382)
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. (2009) (381)
Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. (1995) (377)
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. (2004) (373)
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. (1997) (349)
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. (2005) (341)
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. (2006) (331)
Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. (2005) (296)
Patterns of failure after trimodality therapy for malignant pleural mesothelioma. (1997) (293)
Missense mutations of the BRAF gene in human lung adenocarcinoma. (2002) (286)
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. (2003) (280)
Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. (2000) (259)
High frequency of retinoic acid receptor beta abnormalities in human lung cancer. (1991) (245)
K-ras activation generates an inflammatory response in lung tumors (2006) (244)
Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. (1994) (231)
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. (1996) (226)
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. (1993) (224)
The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. (1997) (213)
Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. (1996) (203)
Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. (2001) (202)
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. (1992) (197)
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. (2006) (189)
Using gene expression ratios to predict outcome among patients with mesothelioma. (2003) (185)
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. (2006) (184)
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. (2005) (182)
Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma (1998) (181)
Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. (2006) (181)
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. (1998) (179)
Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group. (1995) (179)
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. (2006) (174)
Codeletion of p15 and p16 in primary malignant mesothelioma. (1995) (170)
Screening for lung cancer. Another look; a different view. (1997) (170)
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. (2005) (168)
Inflammatory cell distribution within and along asthmatic airways. (1998) (168)
Thoracoscopy in the management of anterior mediastinal masses. (1993) (165)
Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. (2015) (163)
Transcriptome sequencing of malignant pleural mesothelioma tumors (2008) (159)
VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance). (2015) (158)
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients (2008) (152)
Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. (1996) (147)
Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. (2011) (147)
Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. (1999) (146)
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. (1995) (145)
Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? (2004) (144)
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. (2009) (141)
The α folate receptor is highly activated in malignant pleural mesothelioma (2001) (140)
The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma (1999) (139)
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. (2013) (137)
Gene expression in lung adenocarcinomas of smokers and nonsmokers. (2003) (128)
Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238 (2007) (127)
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. (1993) (126)
The safety and versatility of video-thoracoscopy: a prospective analysis of 895 consecutive cases. (1996) (126)
Lung resection in patients with preoperative FEV1 < 35% predicted. (2005) (124)
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. (2009) (123)
Small pulmonary lesions detected at CT: clinical importance. (1997) (121)
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. (2013) (121)
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. (2008) (120)
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. (1991) (120)
Body mass index as a correlate of postoperative complications and resource utilization. (1997) (116)
Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients. (2005) (115)
Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. (2001) (112)
Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer. (2014) (104)
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. (2012) (103)
Malignant effusive disease of the pleura and pericardium. (1997) (103)
Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. (2004) (102)
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma (2010) (102)
Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. (2006) (102)
Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma (1999) (101)
Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest. (2001) (100)
Circulating and tumor‐infiltrating myeloid cells predict survival in human pleural mesothelioma (2011) (99)
Video-assisted thoracic surgery in the elderly. A review of 307 cases. (1996) (98)
Health-related quality of life after elective surgery: measurement of longitudinal changes. (1997) (96)
Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. (1998) (94)
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. (2006) (93)
Surgery for early stage non-small cell lung cancer. (2003) (92)
Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma. (2009) (92)
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility (1999) (90)
Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). (1997) (90)
Surgical resection in the management of small-cell carcinoma of the lung. (1993) (90)
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. (1995) (88)
Extrapleural Pneumonectomy in the Treatment of Epithelioid Malignant Pleural Mesothelioma: Novel Prognostic Implications of Combined N1 and N2 Nodal Involvement Based on Experience in 529 Patients (2014) (88)
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. (2001) (87)
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma (2008) (86)
AXL regulates mesothelioma proliferation and invasiveness (2011) (83)
Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma (2005) (83)
Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. (2005) (83)
CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. (2001) (83)
Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases. (1989) (82)
Mechanical and electrical activity of esophageal smooth muscle during peristalsis. (1984) (82)
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer (2017) (80)
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. (2011) (78)
Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening. (1995) (77)
The alpha folate receptor is highly activated in malignant pleural mesothelioma. (2001) (77)
Management of High-Throughput DNA Sequencing Projects: Alpheus. (2008) (77)
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. (2010) (76)
Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients. (1995) (75)
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. (2002) (75)
Morphologic and functional imaging of malignant pleural mesothelioma. (2007) (75)
Multimodality management of malignant pleural mesothelioma. (1998) (75)
Nitrinergic and peptidergic innervation of the human oesophagus. (1994) (74)
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. (2012) (74)
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. (2004) (74)
Multimodality treatment of diffuse malignant pleural mesothelioma. (2002) (73)
Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research. (1992) (73)
Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. (2002) (73)
Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. (1992) (70)
Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. (2011) (70)
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. (2009) (70)
Semi-supervised recursively partitioned mixture models for identifying cancer subtypes (2010) (70)
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935 (1996) (70)
NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network. (1996) (69)
Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: Evidence for a pathogenetic relationship with lipomas and leiomyomas (1995) (67)
Lung cancer in patients under age 40. (2001) (67)
Second Generation Sequencing of the Mesothelioma Tumor Genome (2010) (67)
Health-related quality of life after elective surgery (1997) (66)
Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. (2009) (66)
Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. (2015) (65)
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma (2008) (64)
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma. (2011) (64)
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. (2003) (64)
Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration. (1998) (62)
Multimodality therapy for malignant pleural mesothelioma. (1997) (62)
A prognostic test for adenocarcinoma of the lung from gene expression profiling data. (2003) (61)
Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases (2010) (61)
Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. (2005) (61)
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. (2009) (61)
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma (2008) (61)
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. (2008) (60)
The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience. (2004) (60)
Factors predicting poor survival after resection of stage IA non-small cell lung cancer. (2007) (59)
Characteristics of malignant pleural mesothelioma in women. (2010) (59)
No-cut thoracoscopic lung plication: a new technique for lung volume reduction surgery. (1997) (58)
Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations. (2007) (57)
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma. (2016) (57)
Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. (2006) (57)
Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. (1992) (56)
Swallowing induces sequential activation of esophageal longitudinal smooth muscle. (1984) (56)
Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury. (1990) (54)
Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma (1999) (52)
Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma. (2010) (52)
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma (2003) (50)
Mesothelioma and radical multimodality therapy: who benefits? (1995) (50)
Pleuropneumonectomy in the treatment of malignant pleural mesothelioma. (1999) (50)
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. (2004) (50)
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery (2009) (50)
Current trends in radiologic management of malignant pleural mesothelioma. (2009) (50)
Pathologic prognostic factors in Barrett's‐associated adenocarcinoma (1999) (49)
Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. (2007) (49)
Surgery for malignant pleural mesothelioma (2010) (49)
Adult Chest Surgery (2009) (48)
Management of the solitary pulmonary nodule: role of thoracoscopy in diagnosis and therapy. (1999) (47)
Surveillance transbronchial lung biopsies: implication for survival after lung transplantation. (2000) (47)
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival (2011) (46)
Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. (2005) (45)
Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. (2013) (44)
The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura. (2011) (43)
Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma. (1993) (43)
Diffuse malignant mesothelioma of the pleural space and its management. (2002) (41)
Alternative conduits for esophageal replacement. (2017) (41)
Neuronal control of esophageal function. (1995) (40)
Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging. (1993) (40)
Innovative therapies: intraoperative intracavitary chemotherapy. (2004) (39)
Influence of age on measurement of health status in patients undergoing elective surgery. (1994) (39)
Peptidergic innervation of the human esophageal smooth muscle. (1991) (39)
Pneumonectomy after chemoradiation (2008) (38)
Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation (2012) (38)
Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival. (1997) (38)
Thoracoscopic staging of esophageal cancer: a prospective, multiinstitutional trial. Cancer and Leukemia Group B Thoracic Surgeons. (1995) (38)
Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening. (1993) (37)
New surgical options for elderly lung cancer patients. (1999) (36)
Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy. (1999) (36)
Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. (2008) (35)
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma (2018) (34)
Malignant mesothelioma of the pleural space. (2000) (34)
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. (2002) (34)
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens. (2010) (34)
Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer. (1999) (34)
Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. (2004) (34)
Benign schwannoma of the esophagus presenting as a giant fibrovascular polyp. (1992) (33)
Malignant pleural mesothelioma. (2001) (33)
Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features (2017) (33)
Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression (2012) (33)
Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. (2013) (32)
A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce (2019) (32)
Influence of Age on Measurement of Health Status in Patients Undergoing Elective Surgery (1993) (32)
Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer (2016) (32)
Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines. (2002) (32)
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma (2018) (32)
Asbestos Burden Predicts Survival in Pleural Mesothelioma (2008) (32)
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma. (2010) (31)
MR imaging of benign and malignant pleural disease. (2008) (31)
Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance). (2016) (30)
Relation Between Preoperative Inspiratory Lung Resistance and the Outcome of Lung-Volume-Reduction Surgery for Emphysema (1999) (30)
The seven attributes of the academic surgeon: Critical aspects of the archetype and contributions to the surgical community. (2017) (30)
Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events (2005) (29)
Surgery versus SABR for resectable non-small-cell lung cancer. (2015) (29)
Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. (2003) (29)
Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study. (1998) (29)
Advances in surgical staging and therapy of non-small-cell lung cancer. (1993) (29)
Preoperative assessment of patients undergoing pulmonary resection. (1993) (28)
Optimal therapy of malignant pleural effusions. (1996) (27)
Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. (2010) (26)
Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages (2016) (26)
Lung cancer • 6: The case for limited surgical resection in non-small cell lung cancer (2003) (26)
Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803. (2013) (26)
Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma. (2008) (25)
The three-hole esophagectomy. The Brigham and Women's Hospital approach (modified McKeown technique). (2000) (25)
Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung (1993) (25)
Thoracoscopic staging and surgical therapy for esophageal cancer. (1995) (25)
Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. (1996) (25)
Patterns of lung involvement by malignant lymphoma. (1993) (25)
Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing (2009) (24)
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma (2019) (24)
Malignant pleural mesothelioma: overview of the North American and European experience. (2004) (24)
Improved technique for hilar vascular stapling. (1992) (24)
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma (2011) (23)
Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program. (2007) (23)
Ethical considerations in lung retransplantation. (1994) (23)
Thoracoscopy and video-assisted thoracic surgery in the treatment of lung cancer. (1995) (22)
Fine-Needle Aspiration Biopsies for Gene Expression Ratio-Based Diagnostic and Prognostic Tests in Malignant Pleural Mesothelioma (2010) (22)
c-MET expression/activation, functions, and mutations in non-small cell lung cancer (2004) (21)
Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: Dynamic contrast‐enhanced MR imaging (2012) (21)
Extent of surgery and survival in early lung carcinoma (2000) (21)
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1. (2004) (20)
A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM) (2007) (20)
Current surgical management of malignant pleural mesothelioma (2002) (19)
Primary mediastinal leiorayoma (1990) (19)
Complications of extrapleural pneumonectomy. (2007) (18)
Extrapleural pneumonectomy in the setting of multimodality therapy for diffuse malignant pleural mesothelioma. (1997) (18)
Genes Associated With Prognosis After Surgery For Malignant Pleural Mesothelioma Promote Tumor Cell Survival In Vitro (2011) (17)
Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. (2010) (17)
Cisplatin, 5‐fluorouracil, and etoposide for advanced non‐small cell lung cancer (1993) (16)
Matrix metalloproteinase 12 promotes tumor propagation in the lung (2018) (16)
Multimodality treatment of malignant superior vena caval syndrome. (1999) (16)
Section V: techniques of esophageal resection. (2003) (16)
Clinical indications and results after chest wall resection for recurrent mesothelioma. (2013) (16)
The American Association for Thoracic Surgery Consensus Guidelines: Reasons and purpose. (2016) (16)
VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study. (2008) (16)
Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma. (2008) (16)
Lung cancer staging and treatment in multidisciplinary trials: Cancer and Leukemia Group B cooperative group approach. Thoracic Surgeons of CALGB. (1999) (15)
Adjuvant chemotherapy (AC) in stage IB non-small cell lung cancer (NSCLC): Long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633. (2011) (15)
Management of Complications After Pneumonectomy. (2015) (15)
Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma (2019) (15)
Sleeve lobectomy, segmentectomy, and thoracoscopy in the management of carcinoma of the lung. (1993) (15)
Primary Ewing sarcoma invading the heart: resection and reconstruction. (2007) (15)
Thorascopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients: Preliminary analysis of a cancer and leukemia group B and Eastern Cooperative Oncology Group phase II trial (2000) (15)
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study. (2003) (14)
Interatrial shunting after major thoracic surgery: a rare but clinically significant event. (2012) (14)
Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancer. (2002) (14)
Video-assisted thoracic surgery pericardial resection for effusive disease. (1998) (14)
Advances in Brief Activating Mutations of the Noonan Syndrome-Associated SHP 2 / PTPN 11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia (2004) (14)
Preoperative chemoradiotherapy alters the expression and prognostic significance of adhesion molecules in Barrett's-associated adenocarcinoma. (2000) (14)
Safety and Efficacy of Radiation Dose Delivered via Iodine-125 Brachytherapy Mesh Implantation for Deep Cavity Sarcomas (2015) (14)
Pneumonectomy for Non-Small Cell Lung Cancer. (2016) (13)
An historical perspective of multi-modality treatment for resectable non-small cell lung cancer. (1995) (13)
New Concepts in the Treatment of Malignant Pleural Mesothelioma. (2018) (13)
Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma (2020) (13)
Intraoperative adjuncts for malignant pleural mesothelioma. (2017) (13)
Role of nitric oxide in human esophageal circular smooth muscle in vitro. (1995) (13)
Chromosomal deletion in patients with malignant pleural mesothelioma. (2009) (12)
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. (1995) (12)
Esophageal physiology and pathophysiology. (1993) (12)
Multimodality management of malignant pleural mesothelioma: introduction. (2009) (11)
Surgical interventions for emphysema. (2007) (11)
Clarity of purpose, focused attention: The essence of excellence. (2014) (11)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two (2016) (11)
Primary mediastinal leiomyoma. (1990) (11)
Preoperative prediction of unresectability in malignant pleural mesothelioma. (2019) (10)
Lung volume reduction surgery for emphysema (2004) (10)
Technique of Extrapleural Pneumonectomy (2010) (10)
Chest wall invasive non-small cell lung cancer: Patterns of failure and implications for a revised staging system (1996) (10)
Surgical staging and work-up of patients with diffuse malignant pleural mesothelioma. (1997) (10)
Selecting the surgical approach to cancer of the esophagus. (1993) (10)
Benign emptying of the postpneumonectomy space. (2011) (9)
A multicenter phase 2 trial of neo-adjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM) (2005) (9)
A phase I study of vaccination with lethally irradiated, autologous nonsmall cell lung carcinoma cells engineered by adenoviral mediated gene transfer to secrete human granulocyte-macrophage colony stimulating factor (2000) (9)
Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery. (2012) (9)
Diagnostic workup of lung cancer. (2011) (9)
Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. (2017) (9)
Extrapleural pneumonectomy for malignant mesothelioma. (1997) (9)
Prospective comparison of open and video assisted lobectomy (1996) (9)
Potential mechanism of vasomotor dysregulation after lung transplantation for primary pulmonary hypertension. (1995) (8)
Single-lung transplantation in situs inversus. (1994) (8)
Perspective on malignant pleural mesothelioma diagnosis and treatment. (2016) (8)
Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma. (2008) (8)
121 Comparison of pre-operative thoracic radiation therapy (TRT) to pre-operative chemotherapy (CT) in surgically staged IIIA(N2) non-small cell lung cancer (NSCLC): Initial results of cancer and leukemia group B (CALGB) phase III protocol 9134 (1997) (7)
PET/CT patterns of treatment failure of malignant pleural mesothelioma (2007) (7)
Nonmalignant diagnoses in patients. Case 2. Lung cancer with mediastinal lymphadenopathy due to amyloidosis. (2000) (7)
A phase I study of carboplatin (Car) and docetaxel (Doc) followed by weekly Car/Doc with concurrent radiotherapy (CT/RT) in patients (pts) with stage III non-small cell lung cancer (NSCLC) (2000) (7)
Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation†. (2018) (7)
Continuous‐infusion cisplatin, 5‐fluorouracil, and leucovorin for advanced non‐small cell lung cancer (1994) (7)
A Proposed System Toward Standardizing Surgery-based Treatments for Malignant Pleural Mesothelioma, From the Joint NCI-IASLC-MARF Taskforce. (2019) (7)
Reciprocal Rb Inactivation and pl 6 INK 4 Expression in Primary Lung Cancers and Cell Lines 1 (2006) (6)
Cardiac sarcoma 14 years after treatment for pleural mesothelioma. (2005) (6)
Extrapleural pneumonectomy for malignant pleural mesothelioma. (2005) (6)
Completion pneumonectomy is safe and effective in select patients with recurrent non-small cell lung cancer (2020) (6)
Gene expression ratio test distinguishes normal lung from lung tumors in solid tissue and FNA biopsies. (2014) (6)
The role of extrapleural pneumonectomy in the management of pleural cancers. (2009) (5)
Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma. (2016) (5)
Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient. (2017) (5)
Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. (2007) (5)
Transhiatal esophagectomy after previous right pneumonectomy. (2014) (5)
Malignant Pleural Effusions After Resection of Pulmonary Adenocarcinoma (1998) (4)
Staged antrectomy and thoracoscopic truncal vagotomy for perforated peptic ulcer disease. (1993) (4)
Postoperative Chylothorax After Thoracoabdominal Aortic Aneurysm Repair. (2018) (4)
Techniques of pneumonectomy. Pleural pneumonectomy. (1999) (4)
Asbestos bodies in lung tissue are associated with pathologic features and patient outcome for epithelial but not non‐epithelial mesothelioma treated by extrapleural pneumonectomy (2009) (4)
Effusion cytology after extrapleural pneumonectomy for treatment of malignant mesothelioma. (1997) (4)
Efficacy and safety of tri-modality treatment in patients with pathologically staged IIIA(N2) nonsmall cell lung cancer (NSCLC) utilizing consolidative thoracic irradiation: results of cancer and leukemia group B (CALGB) trial 8935 (1994) (4)
Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer. (1997) (4)
178 Sequential amifostine and sodium thiosulfate improve renal protection during intracavitary high-dose cisplatin lavage (2006) (3)
Effusive-constrictive pericarditis. (2004) (3)
Total Esophagectomy: The Brigham and Women's Hospital Approach (1999) (3)
Neoadjuvant and adjuvant therapy in the management of locally advanced non-small-cell lung cancer (1993) (3)
Treatment of Malignant Mesothelioma: Extrapleural Pneumonectomy with Intraoperative Chemotherapy (2006) (2)
Imaging , Diagnosis , Prognosis Fine-Needle Aspiration Biopsies for Gene Expression Ratio-Based Diagnostic and Prognostic Tests in Malignant Pleural Mesothelioma (2011) (2)
Impact of pathological staging on survival in patients with epithelial mesothelioma treated with extrapleural pneumonectomy (2007) (2)
A microthymoma and no germinal centre in myasthenia gravis. (2013) (2)
Dr Munden and colleagues respond (1997) (2)
Risk Factors For Atrial Fibrillation Following Extrapleural Pneumonectomy, The Effect Of Prophylactic Beta Blockade (2012) (2)
The influence of radiotherapy technique and dose on the patterns of failure for mesothelioma patients following extrapleural pneumonectomy. (2006) (2)
Preoperative pulmonary vascular morphology and its relationship to postpneumonectomy hemodynamics. (2014) (2)
ESOPHAGECTOMY VIA RIGHT THORACOTOMY (2008) (2)
High-risk bronchoscopy. (2000) (2)
Thoracic Epidural Analgesia after Lung Transplantation (1994) (2)
Lung Cancer Surgery (2011) (2)
174 Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM) (2005) (2)
Dissection of the paratracheal plane, sampling of lymph nodes at station R4 and hemostasis are shown in the short video (2016) (1)
Polymorphism Array Analysis Human Lung Carcinomas Revealed by Single Nucleotide Homozygous Deletions and Chromosome Amplifications in (2005) (1)
O6 Cytoreductive surgery for malignant pleural mesothelioma in the elderly: a single-center experience in 227 patients (2009) (1)
Small Cell Lung Cancer − RNA in Non Therapeutic Inhibition with SU 11274 and Small Interfering Functional Expression and Mutations of c-Met and Its (2005) (1)
Institutional report - Thoracic general Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma (2008) (1)
A neoadjuvant approach to esophageal cancer. (1995) (1)
Esophageal physiology. (1994) (1)
Reply to Waller et al. Standardizing Surgical Treatment for Mesothelioma. (2020) (1)
Advances in the Treatment of Lung Cancer (1997) (1)
118 Technical considerations of extrapleural pneumonectomy (2006) (1)
Session IX: Panel discussion (1993) (1)
731 Gender predicts survival in stage I NSCLC: Clinico-pathologic and molecular analysis of 250 patients (1997) (1)
Outcomes of I-125 Interstitial Planar Seed Brachytherapy for Close or Positive Margins for Thoracic Malignancies (2007) (1)
4529 Eus t staging of esophageal cancer and outcome after neoadjuvant chemoradiotherapy. (2000) (1)
Diffuse malignant pleural mesothelioma: introduction. (1997) (1)
Abstract 4723: Macrophages foster neoplastic progression of malignant mesothelioma and limit response to chemotherapy. (2013) (1)
85 Asbestos burden, epigenetic silencing, and survival in malignant pleural mesothelioma (2006) (1)
Association of mesothelioma outcome with RERG expression (2011) (1)
Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma with Routine PET Imaging. (2020) (1)
P-425 A Phase I trial of extrapleural pneumonectomy and intraoperative,bicavitary, hyperthermic cisplatin lavage with intravenous sodium thiosulfate protection for patients with malignant pleural mesothelioma (2005) (1)
Treatment of Malignant Pleural Mesothelioma: Is There a Benefit to Pleuropneumonectomy? (2007) (1)
The Development of the Brigham and Women’s Multimodality Treatment Plan for Malignant Pleural Mesothelioma: A Model for Improving the Treatment of Rare Diseases (2005) (1)
A Proposed Methodology for Evaluating Secondary Screening (Rescreening) Instruments for Gynecologic Cytology (1998) (1)
Patterns of Local Recurrence for Mesothelioma Patients Treated With Extrapleural Pneumonectomy and Radiation Therapy Using the Electron-Photon Technique: The Dosimetric Challenges of Electron-Photon Match Lines and Blocks (2014) (1)
A Reinterpretation of the Mayo Lung Project Randomized Trial on Lung Cancer Screening (2017) (0)
Periodic screening chest X-rays improve cure rates in lung cancer (1994) (0)
Abstract of papers submitted to the American Motility SocietyRole of nitric oxide (NO) synthesis in secondary peristalsis of opossum esophagus ex-vivo (1994) (0)
Role of substance P in in vitro responses of opossum esophageal circular muscle (1992) (0)
ANTERIOR MEDIASTINAL CAVERNOUS HEMANGIOMA: CASE PRESENTATION AND REVIEW OF LITERATURE (2005) (0)
Pathway in Malignant Pleural Mesothelioma Functional Analysis of c-Met / Hepatocyte Growth Factor (2005) (0)
O-170 Role of estrogen exposure in the presentation, treatment, and survival of women with NSCLC (2003) (0)
Chylothorax and Thrombosed Obtuse Marginal Artery as Initial Manifestations of Behcet's Disease (2012) (0)
Session I: Panel discussion (1993) (0)
Erratum: Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases (0)
Preliminary result of pharmacokinetic parameter evaluation in malignant pleural mesothelioma : Correlation with histology and growth type . (2010) (0)
1035 : Preoperative Chemoradiotherapy Does Not Increase the Risk of Complications for Pneumonectomy in Non-Small-Cell Lung Cancer Patients (2006) (0)
Microarray analysis of thoracic malignancies identifies diagnostic biomarkers and gene functions specific to malignant pleural mesothelioma (2011) (0)
P3.03-028 Nivolumab for Advanced Malignant Pleural Mesothelioma outside of Clinical Trials: A Single Institution Experience: Topic: Mesothelioma Clinical (2017) (0)
SY-5-KL Mesothelioma progress to a cure (2013) (0)
Interim outcome analysis of a prospective phase I trial of surgical resection with intracavitary hyperthermic cisplatin and gemcitabine for patients with resectable malignant pleural mesothelioma. (2013) (0)
63 Prognostic gene ratio test for mesothelioma validated in a prospective clinical trial (2006) (0)
2003 ISolated lung events following radiation for early stage breast cancer: Incidence and predictors for primary lung vs metastatic breast cancer (1995) (0)
Therapist Self-Disclosure: What Does the Research Tell Us? (2019) (0)
Role of nitric oxide (NO) synthesis in secondary peristalsis of opossum esophagus ex-vivo (1994) (0)
Introduction: Multimodality Therapy of Chest Malignancies—Update ’96 (1997) (0)
The new language of lung cancer (2012) (0)
Naturally Occurring IgG Antibodies for the Treatment of Malignant Pleural Mesothelioma (2017) (0)
Use of circulating and tumor-infiltrating myelomonocytic cells to predict survival in human malignant pleural mesothelioma (MPM). (2010) (0)
C6-07: Mutations in the LKB1 tumor suppressor are frequently found in tumors from Caucasian NSCLC patients (2007) (0)
Perfusion MRI of Solitary Pulmonary Nodules at 3 T : Assessment of perfusion parameters and correlation with histology (2009) (0)
Immune Cell Atlas of Thymic Epithelial Tumors Reveals a Cellular Network Signature for Locally Aggressive Tumors (2018) (0)
Unusual case of hemoptysis 13 years after bilobectomy. (2007) (0)
Extrapleural Pneumonectomy for Early-Stage Diffuse Malignant Pleural Mesothelioma (2004) (0)
Threshold of telomerase activity in specific in the detection of non-small cell lung cancer (2000) (0)
Comprar Adult Chest Surgery | David J. Sugarbaker | 9780071434140 | Mcgraw-Hill Education (2009) (0)
Communications to the EditorClarifying Cardiac Decortication Procedure (2003) (0)
Non-small cell lung cancer. (2008) (0)
Pretreatment EUS stage does not predict complete response (CR) to neoadjuvant chemoradiation in esophageal carcinoma (1998) (0)
Prospective validation of a prognostic gene-ratio test for patients undergoing multimodality therapy for malignant pleural mesothelioma (MPM) (2007) (0)
3561 A new technique for the dilatation of completely obstructed esophageal strictures. (2000) (0)
Thoracoscopic Staging andSurgical Therapy forEsophageal Cancer (2017) (0)
Clinicopathologic indices can improve patient selection in malignant mesothelioma. (2012) (0)
Esophageal cancer. Introduction. (2003) (0)
148 Asbestos exposure and genetic susceptibility to malignant pleural mesothelioma (2006) (0)
P18. Elderly Lung Cancer Patients Have the Same Survival Whether Treated With Lobectomy or Wedge Resection (2008) (0)
Abstract 454: Targeting macrophages in a preclinical model of malignant mesothelioma (2011) (0)
7043 A new endoscopic strategy for the treatment of completely obstructing unresectable esophageal cancer. (2000) (0)
High Resolution SNP Arrays Identify Amplified Regions in Lung Cancer (2005) (0)
2135 Does the quality of radiation therapy (RT) impact upon outcome in the tri-modality treatment of stage IIIA(N2) non-small cell lung cancer (NSCLS)?: Analysis of cancer and leukemia group B (CALGB) protocol 8935 (1996) (0)
Urinary KIM-1 for Detection of Acute Kidney Injury after Extrapleural Pneumonectomy. (2009) (0)
Abstract 5257: Manipulating the Noxa/Bim axis undermines the multicellular resistance of 3D tumor spheroids (2012) (0)
Surgical Treatment for Early-Stage Non-Small-Cell Lung Cancer (2002) (0)
Phase I trial of extrapleural pneumonectomy [EPP], and intracavitary intraoperative hyperthermic [IOHC] cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. [MPM] (2007) (0)
LASER RESECTION OF ENDOBRONCHIAL LESIONS: USE OF THE RIGID AND FLEXIBLE BRONCHOSCOPES (1992) (0)
Pleural Mesothelioma Ratio-Based Diagnostic and Prognostic Tests in Malignant Fine-Needle Aspiration Biopsies for Gene Expression (2011) (0)
EML4-ALK fusion gene and sensitivity to an ALK kinase inhibitor in lung cancer (2008) (0)
Aggressive and multiple surgical resections for pulmonary leiomyosarcoma metastases extends survival (2010) (0)
271 Trimodality treatment of surgically staged IIIA (N2) non-small cell lung cancer (NSCLC): Updated analysis of cancer and leukemia group B (CALGB) protocol 8935 (1997) (0)
Activated c-Met receptor tyrosine kinase: A novel molecular therapeutic target for the treatment of malignant pleural mesothelioma (2005) (0)
Book ReviewAtlas of General Thoracic Surgery (1988) (0)
Institutional report - Thoracic oncologic Chromosomal deletion in patients with malignant pleural mesothelioma (2009) (0)
Children and Adolescents (2018) (0)
Current Perspectives in the Treatment of Mesothelioma(招請講演2) (2002) (0)
342-IBIOLOGICAL STERNAL RECONSTRUCTION WITH ILIAC WING BONE AUTOGRAFT AND BIOABSORBABLE PLATES (2013) (0)
Th1-Polarized Macrophages Enhance The Apoptotic Response To Chemotherapy In Mesothelioma (2012) (0)
Genomic Analysis of Thymic Epithelial Tumors Identi fi esNovelSubtypesAssociatedwithDistinct Clinical Features (2017) (0)
Abstract C231: Colony-stimulating factor-1 receptor blockade reprograms malignant mesothelioma tumor microenvironments and decreases tumor growth. (2011) (0)
Introduction: Multimodality Therapy of Chest Malignancies—Update ‘98 (1999) (0)
Mesothelioma andRadical Multimodality Therapy: WhoBenefits?* (2017) (0)
Abstract 3844: Targeting macrophages as a novel therapeutic approach for malignant pleural mesothelioma (2010) (0)
Abstract LB-251: Manipulation of macrophage phenotype enhances the apoptotic response to chemotherapy in mesothelioma (2012) (0)
6613 POSTER Prognostic factors for radical treatment of stage III NSCLC (2007) (0)
Risk Factors for Acute Kidney Injury Following Extrapleural Pneumonectomy. (2009) (0)
O-193 Novel semaphorin- and juxtamembrane-domain mutations ofc-MET in NSCLC: Potential for targeted inhibition (2005) (0)
Abstract 3001: MicroRNAs regulating wnt signaling are downregulated in malignant pleural mesothelioma (2010) (0)
PREDICTIVE VALUE OF POSITIVE CYTOLOGY IN VIDEO-ASSISTED THORACIC SURGERY (VATS) PERICARDIAL WINDOW (2005) (0)
Book ReviewGeneral Thoracic Surgery (1989) (0)
Invited Lecture 1 Advances in the Treatment of Mesothelioma (2007) (0)
Hybrid esophagectomy as a strategy for transition to minimally invasive esophagectomy (2013) (0)
Abstract #1355: AXL is strongly activated and a potential target for therapeutic intervention in mesothelioma (2009) (0)
Free-Breath DCE MRI for Solitary Pulmonary Nodule with Motion Correction Based on Non-Rigid Image Registration (2010) (0)
338: PREDICTIVE RISK MODELING FOR POSTOPERATIVE VENOUS THROMBO-EMBOLISM FOR PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (2012) (0)
Intracardiac Shunting Through Patent Foramen Ovale After Major Thoracic Surgery - A Component Of Postoperative Respiratory Distress (2011) (0)
Retinoic Acid in Pulmonary Fibroblasts Primary Non-Small Cell Lung Cancers and Regulated by Stromelysin-3 Is Overexpressed by Stromal Elements in Updated (2006) (0)
Manipulating The Noxa/Bim Axis Undermines The Multicellular Resistance Of 3D Tumor Spheroids (2012) (0)
Assessment of Ventilation Function and Airway Structure in Mesothelioma Using Hyperpolarized He MRI (2007) (0)
Book ReviewManagement of Esophageal Disease (1989) (0)
Malignant mesothelioma of the pleural space. (2000) (0)
Questionnaire to predict post-operative recovery time of elderly thoracic surgery patients (2013) (0)
Perioperative Ischemic Optic Neuropathy Following Extrapleural Pneumonectomy. (2016) (0)
Therapeutic R2 resection for pleural mesothelioma. (2018) (0)
Incidence, Risk Factors And Economic Burden Of Venous Thromboembolism In Patients With Malignant Pleural Mesothelioma In The Postoperative Period: A 4 Year Retrospective Analysis (2012) (0)
Surgical Treatment of Emphysema: Introduction (2007) (0)
Radiotherapy Following Extrapleural Pneumonectomy(EPP) for Mesothelioma: The Brigham and Women’s Hospital Experience (2005) (0)
Advances in the Treatment of Mesothelioma (2007) (0)
Stage I bronchioloalveolar carcinoma: Results of surgical treatment (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David John Sugarbaker?

David John Sugarbaker is affiliated with the following schools:

David John Sugarbaker's Academic­Influence.com Rankings

Why Is David John Sugarbaker Influential?

David John Sugarbaker's Published Works

Published Works

What Schools Are Affiliated With David John Sugarbaker?

David John Sugarbaker's AcademicInfluence.com Rankings